← SynDRA
DITOLYLGUANIDINE
SynDRA canonical compound SYN0001180 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
| Primary target(s) | GRIN1 | GRIN2A | GRIN2B | SIGMAR1 |
| Mechanism of action | sigma receptor agonist |
All known targets
- GRIN1
- GRIN2A
- GRIN2B
- SIGMAR1
- TMEM97
Mechanisms of action (all sources)
- TMEM97 AGONIST
- sigma receptor agonist
- SIGMAR1 AGONIST
- GRIN1 INHIBITOR
- GRIN2B INHIBITOR
- GRIN2A INHIBITOR
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
- EBP
- ALOX15
- KCNH2
- TDP1
- POLK
- PIN1
- PABPC1
- OPRM1
- OPRK1
- OPRD1
- HDAC6
- ALOX15B
- GNAS
- FEN1
- CYP3A4
- CYP2D6
- CYP2C9
- CYP2C19
- CYP1A2
- TSHR
Screening evidence (raw PubChem HTS — uncurated, known false-positive rate)
- ACM1
- B2CL1
- CP2D6
- GLI3
- GRIN2C
- GRIN2D
- GRIN3A
- GRIN3B
- MCL1
- PABP1
Drug classes
Cross-references
Synonyms
- 1,3-ditolylguanidine
- 1,3-Di-o-tolylguanidine
- Di-o-tolylguanidine
- DOTG
- Vulkacite DOTG
- Vulkacit DOTG
- Eveite DOTG
- Vulkacit dotg/C
- Nocceler DT
- Sanceler DT
- DOTG accelerator
- Soxinol DT
- Akrochem DOTG
- Vulcafor DOTG
- 1,3-Bis(o-tolyl)guanidine
- Guanidine, N,N'-bis(2-methylphenyl)-
- Diorthotolylguanidine
- 1,3-Di-o-tolyguanidine
- N,N'-Di-o-tolylguanidine
- Guanidine, 1,3-di-o-tolyl-
- USAF A-6598
- NSC 473
- CNS 1001
- N,N'-Di-o-tolueylguanidine
- UNII-LL2P01I17O
- 1,3-di-(2-tolyl)guanidine
- NSC 132023
- [3H]-di-o-tolylguanidine
- 1,3-Ditolylguanidine
- 1,2-bis(2-methylphenyl)guanidine
- N,N'-BIS(2-METHYLPHENYL)GUANIDINE
- Guanidine, 1,3-di(2-tolyl)-
- LL2P01I17O
- DTXCID206606
- 1,3-di-ortho-tolyl-guanidine
- RefChem:821755
- DTG
- 1,3-Di-2-tolylguanidine
Look up DITOLYLGUANIDINE in the interactive SynDRA portal →